Impact of neoadjuvant immune checkpoint inhibitor therapy on primary tumor size and complexity: Correlation with surgical quality and short term oncological outcomes. This is an ASCO Meeting Abstract ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results